Skip to content

Utah Medical Products UTMD Provision for Credit Losses

Provision for Credit Losses at other companies

UFP Technologies logo
UFP TechnologiesUFPT
-$38K-124%
Medline, Inc.
 logo
Medline, Inc. MDLN
$1M-96.2%
Baxter International logo
Baxter InternationalBAX
$5M+225%
Avanos Medical logo
Avanos MedicalAVNS
-$400K-500%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's provision for credit losses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's provision for credit losses?
Utah Medical Products (UTMD) reported provision for credit losses of -$5K in Q1 2026.
How has Utah Medical Products's provision for credit losses changed year-over-year?
Utah Medical Products's provision for credit losses increased by 44.4% year-over-year, from -$9K to -$5K.
What does provision for credit losses mean?
Expense recognized to build or adjust allowances for expected credit losses on loans, receivables, and other financial assets, based on forward-looking CECL methodology.